Rhythm Pharmaceuticals, Inc. RYTM Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s other non-current assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported other non-current assets of $2.52M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s other non-current assets decreased by 64.8% year-over-year, from $7.14M to $2.52M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s other non-current assets?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s other non-current assets has grown at a -27.4% compound annual growth rate (CAGR), from $11.82M to $3.29M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.